BeOne Medicines (ONC) Total Debt (2016 - 2025)
Historic Total Debt for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $1.6 billion.
- BeOne Medicines' Total Debt rose 5657.05% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 5657.05%. This contributed to the annual value of $1.0 billion for FY2024, which is 1490.2% up from last year.
- According to the latest figures from Q3 2025, BeOne Medicines' Total Debt is $1.6 billion, which was up 5657.05% from $954.5 million recorded in Q2 2025.
- In the past 5 years, BeOne Medicines' Total Debt ranged from a high of $1.6 billion in Q3 2025 and a low of $488.1 million during Q1 2023
- Over the past 5 years, BeOne Medicines' median Total Debt value was $643.3 million (recorded in 2021), while the average stood at $790.6 million.
- Per our database at Business Quant, BeOne Medicines' Total Debt soared by 28463.44% in 2021 and then plummeted by 1985.02% in 2023.
- Over the past 5 years, BeOne Medicines' Total Debt (Quarter) stood at $629.7 million in 2021, then fell by 19.48% to $507.0 million in 2022, then skyrocketed by 74.74% to $886.0 million in 2023, then rose by 14.9% to $1.0 billion in 2024, then surged by 61.69% to $1.6 billion in 2025.
- Its Total Debt stands at $1.6 billion for Q3 2025, versus $954.5 million for Q2 2025 and $923.6 million for Q1 2025.